Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032

 2.3 Market Size & Forecast, By Segmentation, 2021–2032

  2.3.1 Market Size By Drug Type

  2.3.2 Market Size By Indication

  2.3.3 Market Size By End-use

 2.4 Market Share & Bps Analysis By Region, 2024

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Clinical Development & Approval Metrics

4.1.1 Number of CAR T-cell therapy candidates in clinical trials by phase (Phase I, II, III)
4.1.2 Clinical trial success rate (%) by indication (hematologic vs solid tumors)
4.1.3 Average time from IND submission to regulatory approval

4.2 Manufacturing & Production Statistics

4.2.1 Global CAR T-cell therapy manufacturing capacity (patients/year)
4.2.2 Share of autologous versus allogeneic CAR T therapies in production
4.2.3 Average production cost per therapy and cost reduction trends (2020–2032)

4.3 Market Access & Patient Metrics

4.3.1 Patient access rate (%) in key regions (North America, Europe, Asia-Pacific)
4.3.2 Average treatment wait time from enrollment to infusion
4.3.3 Percentage of eligible patients receiving therapy vs diagnosed patients

4.4 Safety & Efficacy Metrics

4.4.1 Incidence rate of cytokine release syndrome (CRS) and neurotoxicity (%)
4.4.2 Overall response rate (ORR) by indication and therapy type
4.4.3 Duration of response (DoR) and median progression-free survival (PFS)

 5. CAR T-Cell Therapies Market Segmental Analysis & Forecast, By Drug Type, 2021 – 2032, Value (USD Billion)

5.1 Introduction

 5.2 Axicabtagene Ciloleucel (Yescarta)

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2021 – 2032

 5.3 Brexucabtagene Autoleucel (Tecartus)

   5.4 Ciltacabtagene Autoleucel (Carvykti)

5.5 Idecabtagene Vicleucel (Abecma)

5.6 Lisocabtagene Maraleucel (Breyanzi)

5.7 Tisagenlecleucel (Kymriah)

5.8 Others

6. CAR T-Cell Therapies Market Segmental Analysis & Forecast, By Indication, 2021 – 2032, Value (USD Billion)

    6.1 Introduction

 6.2 Acute Lymphoblastic Leukemia

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2021 – 2032

 6.3 Non-Hodgkin Lymphoma

    6.4 Multiple Myeloma

7. CAR T-Cell Therapies Market Segmental Analysis & Forecast, By End-use, 2021 – 2032, Value (USD Billion)

    7.1 Introduction

 7.2 Hospitals

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2021 – 2032

 7.3 Oncology Treatment Centers

8. CAR T-Cell Therapies Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

 8.2.3 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

 8.2.4 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

 8.2.5 CAR T-Cell Therapies Market Size & Forecast, By Country, 2021 – 2032

  8.2.5.1 USA

   8.2.5.1.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.2.5.1.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.2.5.1.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.2.5.2 Canada

   8.2.5.2.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.2.5.2.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.2.5.2.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

8.3 Europe

 8.3.1 Key Trends

 8.3.2 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

 8.3.3 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

 8.3.4 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

 8.3.5 CAR T-Cell Therapies Market Size & Forecast, By Country, 2021 – 2032

  8.3.5.1 Germany

   8.3.5.1.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.1.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.1.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.2 UK

   8.3.5.2.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.2.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.2.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.3 France

   8.3.5.3.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.3.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.3.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.4 Italy

   8.3.5.4.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.4.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.4.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.5 Spain

   8.3.5.5.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.5.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.5.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.6 Russia

   8.3.5.6.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.6.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.6.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.7 Poland

   8.3.5.7.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.7.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.7.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.3.5.8 Rest of Europe

   8.3.5.8.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.3.5.8.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.3.5.8.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

 8.4.3 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

 8.4.4 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

 8.4.5 CAR T-Cell Therapies Market Size & Forecast, By Country, 2021 – 2032

  8.4.5.1 China

   8.4.5.1.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.1.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.1.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.4.5.2 India

   8.4.5.2.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.2.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.2.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.4.5.3 Japan

   8.4.5.3.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.3.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.3.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.4.5.4 South Korea

   8.4.5.4.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.4.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.4.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.4.5.5 Australia

   8.4.5.5.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.5.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.5.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.4.5.6 ASEAN Countries

   8.4.5.6.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.6.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.6.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.4.5.7 Rest of Asia-Pacific

   8.4.5.7.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.4.5.7.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.4.5.7.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

 8.5.3 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

 8.5.4 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

 8.5.5 CAR T-Cell Therapies Market Size & Forecast, By Country, 2021 – 2032

  8.5.5.1 Brazil

   8.5.5.1.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.5.5.1.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.5.5.1.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.5.5.2 Argentina

   8.5.5.2.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.5.5.2.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.5.5.2.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.5.5.3 Mexico

   8.5.5.3.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.5.5.3.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.5.5.3.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.5.5.4 Colombia

   8.5.5.4.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.5.5.4.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.5.5.4.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.5.5.5 Rest of Latin America

   8.5.5.5.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.5.5.5.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.5.5.5.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

 8.6.3 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

 8.6.4 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

 8.6.5 CAR T-Cell Therapies Market Size & Forecast, By Country, 2021 – 2032

  8.6.5.1 UAE

   8.6.5.1.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.6.5.1.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.6.5.1.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.6.5.2 Saudi Arabia

   8.6.5.2.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.6.5.2.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.6.5.2.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.6.5.3 Qatar

   8.6.5.3.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.6.5.3.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.6.5.3.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.6.5.4 Egypt

   8.6.5.4.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.6.5.4.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.6.5.4.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.6.5.5 South Africa

   8.6.5.5.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.6.5.5.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.6.5.5.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

  8.6.5.6 Rest of Middle East & Africa

   8.6.5.6.1 CAR T-Cell Therapies Market Size & Forecast, By Drug Type, 2021 – 2032

   8.6.5.6.2 CAR T-Cell Therapies Market Size & Forecast, By Indication, 2021 – 2032

   8.6.5.6.3 CAR T-Cell Therapies Market Size & Forecast, By End-use, 2021 – 2032

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2024

  9.2.2 Year-Wise Strategies & Development, 2021 – 2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2024

 9.3 Market Share Analysis, 2024

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

 9.6.1 Gilead Sciences, Inc.

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Novartis AG

9.6.3 Bristol-Myers Squibb Company

9.6.4 Johnson & Johnson Services, Inc. (Janssen Global Services, LLC)

9.6.5 Caribou Biosciences, Inc.

9.6.6 CARsgen Therapeutics Co., Ltd

9.6.7 JW Therapeutics (Shanghai) Co., Ltd.

9.6.8 Cartesian Therapeutics, Inc.

9.6.9 Aurora Biopharma

9.6.10 Merck KGaA

9.6.11 TCR2 Therapeutics Inc

9.6.12 Bluebird Bio Inc.

9.6.13 Sorrento Therapeutics

9.6.14 Fate Therapeutics

9.6.15 Pfizer Inc.

9.6.16 Amgen

9.6.17 Celgene Corporation

9.6.18 Editas Medicine

9.6.19 CRISPR Therapeutics

9.6.20 Allogene Therapeutics

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures